Barclays Portfolio holdings
Barclays is a British universal bank whose roots go back to 1690, when the Quakers John Freame and Thomas Gould started a goldsmith banking business in London. The Barclays name came into the business in 1736, when James Barclay, son-in-law of founder John Freame, became a partner. Barclays launched the UK's first credit card, Barclaycard, in 1966, and in 1967 put the world's first cash machine in a branch in Enfield. In 2008 Barclays bought the North American operations of Lehman Brothers, and in 2009 it sold its Barclays Global Investors unit, home of the iShares ETFs, to BlackRock. It runs five divisions: UK consumer banking, UK corporate banking, private banking and wealth management, an investment bank and a US consumer bank.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$17.5B |
| 2 |
NVIDIA
NVDA
|
+$2.7B |
| 3 |
Intel
INTC
|
+$1.98B |
| 4 |
Broadcom
AVGO
|
+$1.46B |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$1.11B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$35.8B |
| 2 |
Apple
AAPL
|
+$1.83B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$913M |
| 4 |
Microsoft
MSFT
|
+$856M |
| 5 |
Bank of America
BAC
|
+$792M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 49.47% |
| 2 | Technology | 19.84% |
| 3 | Consumer Discretionary | 7.61% |
| 4 | Financials | 5.61% |
| 5 | Communication Services | 3.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2826
Albany International
AIN
$1.94B
| $1.35M | ﹤0.01% |
22,655
+13,841
| +157% | +$906K |
2016 Q1
42 quarters
|
|
2827
Banco Bradesco
BBD
$28.7B
| $1.35M | ﹤0.01% |
382,638
-243,338
| -39% | -$835K |
2013 Q2
53 quarters
|
|
2828
CALL
Credo Technology Group
CRDO
$26.6B
| $1.34M | ﹤0.01% |
+6,900
| New | +$1.49M |
2026 Q3
0 quarters
|
|
2829
Slide Insurance Holdings
SLDE
$3.05B
| $1.34M | ﹤0.01% |
60,221
+32,284
| +116% | +$719K |
2025 Q2
5 quarters
|
|
2830
Castle Biosciences
CSTL
$1.05B
| $1.34M | ﹤0.01% |
37,747
+7,417
| +24% | +$224K |
2022 Q1
18 quarters
|
|
2831
Vita Coco
COCO
$3.73B
| $1.34M | ﹤0.01% |
23,418
-8,145
| -26% | -$517K |
2022 Q1
18 quarters
|
|
2832
Galaxy Digital Inc
GLXY
$3.06B
| $1.34M | ﹤0.01% |
58,803
-10,369
| -15% | -$242K |
2025 Q2
5 quarters
|
|
2833
FMC
FMC
$879M
| $1.34M | ﹤0.01% |
149,905
+36,998
| +33% | +$404K |
2013 Q2
53 quarters
|
|
2834
Sharplink Inc
SBET
$1.31B
| $1.33M | ﹤0.01% |
143,516
-527,127
| -79% | -$3.85M |
2025 Q3
4 quarters
|
|
2835
WaFd
WAFD
$2.17B
| $1.33M | ﹤0.01% |
44,467
+13,737
| +45% | +$493K |
2013 Q2
53 quarters
|
|
2836
Stoke Therapeutics
STOK
$1.82B
| $1.33M | ﹤0.01% |
51,185
+36,579
| +250% | +$1.1M |
2019 Q2
29 quarters
|
|
2837
MannKind Corp
MNKD
$1.35B
| $1.33M | ﹤0.01% |
341,143
+92,646
| +37% | +$363K |
2019 Q1
30 quarters
|
|
2838
CALL
JD.com
JD
$37.6B
| $1.32M | ﹤0.01% |
+49,800
| New | +$1.44M |
2026 Q3
0 quarters
|
|
2839
Ambarella
AMBA
$2.76B
| $1.32M | ﹤0.01% |
19,026
+13,002
| +216% | +$941K |
2013 Q4
51 quarters
|
|
2840
Republic Bancorp
RBCAA
$1.79B
| $1.32M | ﹤0.01% |
14,390
+8,996
| +167% | +$851K |
2016 Q1
42 quarters
|
|
2841
CALL
Autodesk
ADSK
$54.3B
| $1.32M | ﹤0.01% |
6,300
+4,200
| +200% | +$958K |
2025 Q3
4 quarters
|
|
2842
Editas Medicine
EDIT
$366M
| $1.31M | ﹤0.01% |
510,903
+361,639
| +242% | +$1.06M |
2016 Q3
40 quarters
|
|
2843
FormFactor
FORM
$7.51B
| $1.31M | ﹤0.01% |
8,777
-19,352
| -69% | -$2.21M |
2013 Q2
53 quarters
|
|
2844
Aktis Oncology
AKTS
$948M
| $1.3M | ﹤0.01% |
66,716
-84,980
| -56% | -$2.07M |
2026 Q1
2 quarters
|
|
2845
Madison Square Garden
MSGE
$3.78B
| $1.3M | ﹤0.01% |
16,199
+9,888
| +157% | +$775K |
2023 Q2
13 quarters
|
|
2846
DELISTED
Atkore
ATKR
| $1.3M | ﹤0.01% |
13,691
-183,818
| -93% | -$15.9M |
2016 Q4
39 quarters
|
|
2847
Transcat
TRNS
$989M
| $1.3M | ﹤0.01% |
14,648
+5,628
| +62% | +$497K |
2019 Q1
30 quarters
|
|
2848
Mercantile Bank Corp
MBWM
$1.06B
| $1.29M | ﹤0.01% |
22,185
+242
| +1% | +$14.4K |
2016 Q2
41 quarters
|
|
2849
Navigator Holdings
NVGS
$1.28B
| $1.29M | ﹤0.01% |
55,768
+10,208
| +22% | +$223K |
2019 Q2
29 quarters
|
|
2850
PUT
Devon Energy
DVN
$51.2B
| $1.29M | ﹤0.01% |
+28,000
| New | +$1.29M |
2026 Q3
0 quarters
|
|
Similar funds
Barclays's Q3 2026 Portfolio in Review
As of Q3 2026, Barclays held 5,855 positions worth $500B, down 4% from $521B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Barclays withdrew a net $19B in Q3 2026, closing 474 positions and reducing 1,494 holdings. Its most notable exit was ExxonMobil, an estimated $761M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 49% of assets, down from 55% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Barclays opened a new position in iShares Broad USD High Yield Corporate Bond ETF worth $199M.
- Barclays's largest Q3 2026 buy was iShares Broad USD High Yield Corporate Bond ETF: 5,582,517 shares worth $199M.
- Barclays added most to Tesla in Q3 2026, an estimated $17.5B increase.
- Barclays's biggest Q3 2026 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $35.8B.
- Barclays fully exited ExxonMobil in Q3 2026, selling an estimated $761M.
- Barclays's ten largest holdings make up 40% of its $500B portfolio in Q3 2026.
- Barclays opened 525 new positions and closed 474 in Q3 2026.
- Barclays's portfolio value fell 4% quarter-over-quarter to $500B.
Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.